Levent Akduman
Script error: No such module "Draft topics". Script error: No such module "AfC topic".
| Levent Akduman | |
|---|---|
 Levent Akduman at the Winning Pitch Challenge | |
| Born | Turkey |
| 🏳️ Nationality | Turkish-American |
| 🏫 Education | Hacettepe University (MD) Gazi University (Residency in Ophthalmology) Washington University in St. Louis (Fellowships in Uveitis and Vitreoretinal Surgery) |
| 💼 Occupation | |
| Known for | Development of the Staphyloma Supporting Device |
| Title | CEO of LA Eye |
| 🏅 Awards | Winning Pitch Challenge (Retina category, 2022) |
| 🌐 Website | Quantum Vision Centers Profile |
Levent Akduman is a Turkish-American ophthalmologist and entrepreneur recognized for his advancements in retinal surgery and the development of the Staphyloma Supporting Device.[1][2] He serves as a board-certified retina surgeon at Quantum Vision Centers in the St. Louis Metro East area and is the CEO of LA Eye.[2][3]
Early life and education[edit]
Levent Akduman was born in Turkey and pursued his medical education at Hacettepe University in Ankara, where he earned his medical degree in 1988.[3] Following his graduation, he completed an internship and residency in Ophthalmology at Gazi University Medical School, concluding his residency in 1993.[4]
Dr. Akduman further specialized in the United States by undertaking fellowships at Washington University in St. Louis School of Medicine in 1996, focusing on Uveitis and Vitreoretinal Surgery.[4]
Career[edit]
Medical Practice[edit]
Dr. Akduman is a board-certified ophthalmologist with over 30 years of experience. His professional interests include advanced cataract surgery, intraocular lens implantation, corneal transplantation, diabetic retinopathy, Usher syndrome, uveitis, vitrectomy, and diseases and treatments of the vitreous and retina.[5] He is affiliated with several professional organizations, including the American Academy of Ophthalmology, the American Board of Ophthalmology, the American Society of Cataract & Refractive Surgeons, the American Uveitis Society, and the Association of Research in Vision and Ophthalmology.[3]
Entrepreneurial Ventures[edit]
Dr. Akduman is the CEO of LA Eye, a company developing ophthalmic implants. His notable invention, the Staphyloma Supporting Device, is designed to address pathologic myopia by reshaping the posterior sclera to a more natural form and reducing axial length to treat or prevent blinding myopic maculopathy.[6]
In 2022, Dr. Akduman won the Winning Pitch Challenge in the Retina category for his invention, the Staphyloma Supporting Device, which was subsequently patented.[2] The implant has been successfully applied to patients in Turkey, demonstrating its potential in treating severe vision problems related to high myopia.[7]
Dr. Akduman is actively seeking FDA approval for his implant to facilitate its commercial production and global availability.[7]
Inventions and Patents[edit]
Dr. Akduman holds a patent for the Staphyloma Supporting Device, assigned to LA Eye. This device is a surgical implant designed to improve, support, or help preserve vision by altering the axial length or curvature of the eye.[8]
The Staphyloma Supporting Device is constructed as a unitary implant from a single base material, such as titanium alloy, ensuring structural rigidity and longevity. The device features a macular indenter plate that is wider than the implant body, and an anchor structure that is wider than the macular indenter plate. This design allows for a compound concavity scleral contact surface, which closely approximates the outer surface of the eye. The anterior radius of curvature works in tandem with a posterior radius of curvature that is smaller, enabling the restoration of macular shape and axial length.[9]
The design of the implant allows for better integration with the scleral surface, enhancing the stability and effectiveness of the surgical procedure. By restoring the natural curvature and reducing the axial length, the device aims to correct severe myopia and prevent associated retinal pathologies.[9]
Awards and honors[edit]
In 2022, Dr. Akduman was awarded first place in the 'Retina' category at the Winning Pitch Challenge for his invention, the Staphyloma Supporting Device.[2]
Personal life[edit]
Dr. Akduman resides in the United States and maintains strong ties with the Turkish medical community.[1] His work has significantly impacted patients suffering from severe myopia, offering new hope through advanced surgical interventions.[7]
References[edit]
- ↑ 1.0 1.1 @yirmidorttv. "[Turkish National News Interview Recording]" (Tweet) (in Turkish). Retrieved October 7, 2024 – via Twitter.CS1 maint: Unrecognized language (link) Missing or empty |date= (help)
- ↑ 2.0 2.1 2.2 2.3 "Winning Pitch Challenge". Winning Pitch Challenge. 28 April 2022. Retrieved October 6, 2024.
- ↑ 3.0 3.1 3.2 "About Dr. Levent Akduman". Quantum Vision Centers. Retrieved October 6, 2024.
- ↑ 4.0 4.1 "Levent Akduman, MD". Cox Health. Retrieved October 6, 2024.
- ↑ "Overview". U.S. News & World Report. Retrieved October 6, 2024.
- ↑ "MacularBuckle". MacularBuckle. Retrieved October 6, 2024.
- ↑ 7.0 7.1 7.2 "Turkish doctor breaks new ground in vision". Hurriet (in Turkish). June 13, 2022. Retrieved October 7, 2024.CS1 maint: Unrecognized language (link)
- ↑ "Patents Assigned to LA EYE LLC". Justia Patents. Retrieved October 6, 2024.
- ↑ 9.0 9.1 12070387, Levent Akduman, "Staphyloma supporting device and method for modifying the axial length and curvature of an eye", assigned to LA EYE LLC
External links[edit]
This article "Levent Akduman" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Levent Akduman. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
